Apollo Hospitals Enterprise Management Guidance Tracker

Apollo 24/7 is on track to achieve breakeven by end of FY26, with losses narrowing to ₹73 crore in Q1 from ₹116 crore last year.

Healthcare services margins are expected to improve from 24.5% to 25% or higher, before a marginal 100 bps dip from new hospital losses.

Pre-opening EBITDA losses from six new hospitals are expected to be around ₹150 crore, with break-even targeted within 12 months.

Apollo HealthCo aims for a revenue run rate of ₹25,000 crore and 7% EBITDA margin by Q4 FY27, with current H1 margin at 4.4%.

Management expects total pre-opening and ramp-up losses of around ₹150 crore for new hospitals in the next fiscal year.

Management expects to improve existing hospital EBITDA margins by about 100 basis points through asset utilization and cost initiatives.

Four new hospitals (women's oncology in Delhi, multispeciality in Pune, acquired hospital in Bangalore, multispeciality in Kolkata) will add 700 beds in FY26.

Approximately 750 beds to be operationalized in FY27 across Hyderabad, Kolkata, Bangalore, and Gurugram, with the balance in early FY28.

The merged entity (Apollo Healthco + Keimed) is expected to achieve a revenue run rate of ₹25,000 crore with 7% EBITDA margin by end of FY27.

Management expects healthcare services revenue growth to revert to 13% as Bangladesh patients return and new markets are explored.

The digital platform is on course to achieve break-even by end of this fiscal year, though insurance investments may cause a slight delay.

Cash EBITDA break-even for Apollo 24/7 delayed by one quarter due to insurance revenue recognition mismatch; otherwise on track.